Glycocalyx modulation is a physiological means of regulating cell adhesion.
Here we present experimental evidence that phagocytic cells use modulation of specific components of their glycocalyx to regulate their binding capacity. Particles coated with antibodies specific for the CD32 medium affinity IgG receptor were driven along human monocytic THP-1 cells (expressing CD32) in a flow chamber operated at low shear rate. Surprisingly, only minimal adhesion was observed. However, when cells were activated by exposure to fibronectin-coated surfaces and/or soluble &ggr; interferon, adhesion efficiency was dramatically increased, whereas the apparent glycocalyx thickness displayed 20% decrease, and the surface density of CD43/leukosialin carbohydrate epitopes displayed 30-40% decrease on activated cells. The existence of a causal link between adhesion increase and glycocalyx alteration was strongly supported by the finding that (i) both phenomena displayed similar kinetics, (ii) an inverse relationship between THP-1 cell binding capacity and glycocalyx density was demonstrated at the individual cell level, and (iii) adhesion enhancement could not be ascribed to an increased binding site density or improved functional capacity of activated cells. Additional experiments revealed that cell-to-particle adhesion resulted in delayed (i.e. more than a few minutes) egress of CD43/leukosialin from contact areas. Since the time scale of particle attachment was less than a second, surface mobility should not affect the potential of CD43 to impair the initial step of adhesion. Finally, studies performed with fluorescent lectins suggested that THP-1 cell activation and increased adhesive potential were related to a decrease of O-glysosylation rather than N-glycosylation of surface glycoproteins.
Sabri
S
S
Laboratoire d'Immunologie, INSERM U 387, Hôpital de Sainte-Marguerite, BP 29, France.
Soler
M
M
Foa
C
C
Pierres
A
A
Benoliel
A
A
Bongrand
P
P
D002448:Cell Adhesion / Q000502:physiology*; D002460:Cell Line; D000939:Epitopes / Q000276:immunology; D005353:Fibronectins / Q000378:metabolism; D019276:Glycocalyx / Q000502:physiology* / Q000648:ultrastructure; D006031:Glycosylation; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D008853:Microscopy / Q000379:methods; D017452:Receptors, IgG / Q000276:immunology
D000939:Epitopes; D005353:Fibronectins; D017452:Receptors, IgG; D007371:Interferon-gamma